According to Spectrum Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.10 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | S$0.10 B | 16.91% |
2021-12-31 | S$86.51 M | 4.54% |
2020-12-31 | S$82.75 M | -15.96% |
2019-12-31 | S$98.47 M | -33.03% |
2018-12-31 | S$0.14 B | -19.23% |
2017-12-31 | S$0.18 B | -34.74% |
2016-12-31 | S$0.27 B | -5.35% |
2015-12-31 | S$0.29 B | -5.27% |
2014-12-31 | S$0.31 B | 12.89% |
2013-12-31 | S$0.27 B | 1.79% |
2012-12-31 | S$0.27 B | 125.14% |
2011-12-31 | S$0.12 B | 4.73% |
2010-12-31 | S$0.11 B | 26.22% |
2009-12-31 | S$90.98 M | -10.21% |
2008-12-31 | S$0.10 B | 701% |
2007-12-31 | S$12.65 M | 13.51% |
2006-12-31 | S$11.14 M | 64.5% |
2005-12-31 | S$6.77 M | 46.02% |
2004-12-31 | S$4.63 M | -12.14% |
2003-12-31 | S$5.28 M | 9.44% |
2002-12-31 | S$4.82 M | -56.83% |
2001-12-31 | S$11.17 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Teva Pharmaceutical Industries TEVA | S$40.95 B | 39,650.22% | ๐ฎ๐ฑ Israel |
![]() Seagen
SGEN | S$1.38 B | 1,240.23% | ๐บ๐ธ USA |
![]() Curis CRIS | S$58.51 M | -43.20% | ๐บ๐ธ USA |
![]() Biogen BIIB | S$14.08 B | 13,569.35% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | S$95.52 B | 92,615.47% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | S$41.25 B | 39,944.52% | ๐บ๐ธ USA |
![]() Novartis NVS | S$78.33 B | 75,934.38% | ๐จ๐ญ Switzerland |
![]() Johnson & Johnson JNJ | S$147.22 B | 142,798.48% | ๐บ๐ธ USA |
![]() Pfizer PFE | S$149.55 B | 145,060.13% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | S$77.45 B | 75,075.10% | ๐ฌ๐ง UK |